Efficacy and Safety of Enzalutamide Plus ADT Versus Placebo Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer: The Arches Trial-MedSci.cn

Efficacy and Safety of Enzalutamide Plus ADT Versus Placebo Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer: The Arches Trial

Stenzl, A; Azad, A; Krivoshik, A; Baron, B; Hirmand, M; Armstrong, A

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017; 13 ( ): 73

科室
- - 订阅+
  - 更多科室
工具
服务